Advertisement Covers CROI 2017


Research Shows 47% Reduction in STIs Among Gay Men Who Took Doxycycline After Sex

February 16, 2017

The antibiotic doxycycline, when taken within 72 hours of condomless sex, can reduce the risk of bacterial sexually transmitted infections (STIs) by 47%, new research presented at CROI this week showed. The antibiotic significantly reduced the number of chlamydia and syphilis infections, but did not reduce gonorrhea infections.

Jean-Michel Molina, the lead investigator of the IPERGAY on-demand PrEP study, presented results of the study conducted with a group of men who have sex with men (MSM) enrolled in the open-label portion of the IPERGAY study.

"We've seen in the last couple of years an increase in the number of STIs across Europe, North America and other countries including Australia, especially among MSM. It would be fair to acknowledge the increase actually pre-dates PrEP. Nevertheless, high rates of STIs have been reported among MSM on PrEP, and in the two European PrEP studies PROUD and IPERGAY, the proportion of men reporting an STI ranged from 41% [in IPERGAY] and 57% [in PROUD]. PrEP programs give a unique opportunity to foster research in testing, treatment and prevention of STIs," he said.

This excerpt was cross-posted with the permission of Read the full article.

Related Stories

Study Suggests STI Testing and Treatment as Part of PrEP Care May Reduce Bacterial STIs Among Gay and Bisexual Men

This article was provided by BETA. It is a part of the publication The 24th Conference on Retroviruses and Opportunistic Infections. Visit their website at

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.